Implementation of point-of-care genetic testing for head and neck paragangliomas: early experience and future directions
POC genetic testing for HNPGLs increases testing rates and allows for earlier risk identification for patients with head and neck paragangliomas. Our data support institutional integration of point-of-care models into routine care.
Authors
- Nikhil Bellamkonda (ORCID: https://orcid.org/0000-0001-8170-7160)
- Michelle J. White (ORCID: https://orcid.org/0000-0002-1944-1995)
- Luke Buchmann
- Hilary C. McCrary (ORCID: https://orcid.org/0000-0002-9523-0727)
- Anne Naumer
- Mana Espahbodi (ORCID: https://orcid.org/0000-0002-2822-778X)
- Jacob Beiriger (ORCID: https://orcid.org/0000-0001-8552-787X)
- Neil S. Patel (ORCID: https://orcid.org/0000-0002-6580-3053)
- Shi Liang
Institutions
- University of Utah (US)
Publication Details
- Journal
- Oral Oncology
- Published
- 2025-08-12
- DOI
- https://doi.org/10.1016/j.oraloncology.2025.107600
- Citations
- 3
- Primary Topic
- Adrenal and Paraganglionic Tumors
- Type
- article
- Field-Weighted Citation Impact
- 6.02